logo
#

Latest news with #EntrepreneurOfTheYear2025Mid-AtlanticAward

JIM BUCK OF MEDCURA, INC. NAMED EY US ENTREPRENEUR OF THE YEAR® 2025 MID-ATLANTIC AWARD FINALIST
JIM BUCK OF MEDCURA, INC. NAMED EY US ENTREPRENEUR OF THE YEAR® 2025 MID-ATLANTIC AWARD FINALIST

Yahoo

time15-05-2025

  • Business
  • Yahoo

JIM BUCK OF MEDCURA, INC. NAMED EY US ENTREPRENEUR OF THE YEAR® 2025 MID-ATLANTIC AWARD FINALIST

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future COLLEGE PARK, Md., May 15, 2025 /PRNewswire/ -- Medcura, Inc. today announced that President, CEO & Director Jim Buck, MBA is an Ernst & Young LLP (EY US) finalist for the prestigious Entrepreneur Of The Year 2025 Mid-Atlantic Award. Now in its 40th year, the Entrepreneur Of The Year program honors the bold leaders who disrupt markets through the world's most ground-breaking companies, revolutionizing industries and making a profound impact on communities. The program highlights intrepid entrepreneurs whose innovations shape the future and pave the way for a thriving economy and a hopeful tomorrow. The Mid-Atlantic program celebrates entrepreneurs from Maryland, Virginia and Washington, DC. An independent panel of judges selected Buck as a finalist for his entrepreneurial spirit, transformational ingenuity, and lasting impact in building long-term value. Buck has a proven track record of innovation and entrepreneurship, having led the development and commercialization of multiple medical device technologies — including an interventional implantable cardioverter defibrillator, a minimally invasive device for mitral valve repair, portable MRI systems for intraoperative margin assessment, and synthetic polymer biosurgery technologies. At Medcura, Buck leads the development and commercialization of innovative hemostasis solutions that deploy patented biopolymer technologies to control surgical bleeding. LifeGel™, Medcura's lead product for controlling bleeding in spine surgery, is the first and only absorbable hemostatic gel to receive FDA Breakthrough Device Designation. "LifeGel is just the beginning," says Buck. "The same biopolymer powering LifeGel has far-reaching potential across surgical applications. Our development pipeline includes additional indications and new delivery formats—bellows applicators, films, powders, and textiles — each designed to offer safer, more effective, and cost-efficient bleeding control for surgeons and trauma teams." Entrepreneur Of The Year honors business leaders for their ingenuity, courage and entrepreneurial spirit. The program celebrates original founders who bootstrapped their business from inception or who raised outside capital to grow their company; transformational CEOs who infused innovation into an existing organization to catapult its trajectory. Regional award winners will be announced on June 18 during a special celebration in Washington, DC, and will become lifetime members of an esteemed community of Entrepreneur Of The Year alumni from around the world. The winners will then be considered by the National judges for the Entrepreneur Of The Year National Awards, which will be presented in November at the annual Strategic Growth Forum®, one of the nation's most prestigious gatherings of high-growth, market-leading companies. About MedcuraMedcura, Inc. is a commercial-stage medical device company developing versatile hemostatic products serving large surgical, medical, and consumer market opportunities. The Company's proprietary technology platform combines the use of safe, inert ingredients with patented chemistries, all aimed at introducing disruptively lower cost products capable of safely and effectively controlling bleeding across a broad spectrum of clinical applications. Medcura has received FDA Breakthrough Device Designations for LifeGel™, which controls surgical bleeding for spine surgeries, and LifeFoam™, a hemostatic agent for traumatic wounds. Learn more about Medcura's growing product line at About EYEY is building a better working world by creating new value for clients, people, society and the planet, while building trust in capital markets. For more information about our organization, please visit Disclaimer: LifeGel and its application tips are currently in development. All marketing claims, intended uses, and/or indications for use for this medical device and its application tips have not been cleared or approved by the FDA. Media ContactSteven FordSr. VP of Marketing & Business Developmentsford@ 466-6530 View original content to download multimedia: SOURCE Medcura Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

JIM BUCK OF MEDCURA, INC. NAMED EY US ENTREPRENEUR OF THE YEAR® 2025 MID-ATLANTIC AWARD FINALIST
JIM BUCK OF MEDCURA, INC. NAMED EY US ENTREPRENEUR OF THE YEAR® 2025 MID-ATLANTIC AWARD FINALIST

Yahoo

time15-05-2025

  • Business
  • Yahoo

JIM BUCK OF MEDCURA, INC. NAMED EY US ENTREPRENEUR OF THE YEAR® 2025 MID-ATLANTIC AWARD FINALIST

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future COLLEGE PARK, Md., May 15, 2025 /PRNewswire/ -- Medcura, Inc. today announced that President, CEO & Director Jim Buck, MBA is an Ernst & Young LLP (EY US) finalist for the prestigious Entrepreneur Of The Year 2025 Mid-Atlantic Award. Now in its 40th year, the Entrepreneur Of The Year program honors the bold leaders who disrupt markets through the world's most ground-breaking companies, revolutionizing industries and making a profound impact on communities. The program highlights intrepid entrepreneurs whose innovations shape the future and pave the way for a thriving economy and a hopeful tomorrow. The Mid-Atlantic program celebrates entrepreneurs from Maryland, Virginia and Washington, DC. An independent panel of judges selected Buck as a finalist for his entrepreneurial spirit, transformational ingenuity, and lasting impact in building long-term value. Buck has a proven track record of innovation and entrepreneurship, having led the development and commercialization of multiple medical device technologies — including an interventional implantable cardioverter defibrillator, a minimally invasive device for mitral valve repair, portable MRI systems for intraoperative margin assessment, and synthetic polymer biosurgery technologies. At Medcura, Buck leads the development and commercialization of innovative hemostasis solutions that deploy patented biopolymer technologies to control surgical bleeding. LifeGel™, Medcura's lead product for controlling bleeding in spine surgery, is the first and only absorbable hemostatic gel to receive FDA Breakthrough Device Designation. "LifeGel is just the beginning," says Buck. "The same biopolymer powering LifeGel has far-reaching potential across surgical applications. Our development pipeline includes additional indications and new delivery formats—bellows applicators, films, powders, and textiles — each designed to offer safer, more effective, and cost-efficient bleeding control for surgeons and trauma teams." Entrepreneur Of The Year honors business leaders for their ingenuity, courage and entrepreneurial spirit. The program celebrates original founders who bootstrapped their business from inception or who raised outside capital to grow their company; transformational CEOs who infused innovation into an existing organization to catapult its trajectory. Regional award winners will be announced on June 18 during a special celebration in Washington, DC, and will become lifetime members of an esteemed community of Entrepreneur Of The Year alumni from around the world. The winners will then be considered by the National judges for the Entrepreneur Of The Year National Awards, which will be presented in November at the annual Strategic Growth Forum®, one of the nation's most prestigious gatherings of high-growth, market-leading companies. About MedcuraMedcura, Inc. is a commercial-stage medical device company developing versatile hemostatic products serving large surgical, medical, and consumer market opportunities. The Company's proprietary technology platform combines the use of safe, inert ingredients with patented chemistries, all aimed at introducing disruptively lower cost products capable of safely and effectively controlling bleeding across a broad spectrum of clinical applications. Medcura has received FDA Breakthrough Device Designations for LifeGel™, which controls surgical bleeding for spine surgeries, and LifeFoam™, a hemostatic agent for traumatic wounds. Learn more about Medcura's growing product line at About EYEY is building a better working world by creating new value for clients, people, society and the planet, while building trust in capital markets. For more information about our organization, please visit Disclaimer: LifeGel and its application tips are currently in development. All marketing claims, intended uses, and/or indications for use for this medical device and its application tips have not been cleared or approved by the FDA. Media ContactSteven FordSr. VP of Marketing & Business Developmentsford@ 466-6530 View original content to download multimedia: SOURCE Medcura

Gautam Ijoor Announced as an EY Entrepreneur Of The Year® 2025 Mid-Atlantic Award finalist
Gautam Ijoor Announced as an EY Entrepreneur Of The Year® 2025 Mid-Atlantic Award finalist

Associated Press

time29-04-2025

  • Business
  • Associated Press

Gautam Ijoor Announced as an EY Entrepreneur Of The Year® 2025 Mid-Atlantic Award finalist

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future VIENNA, Va., April 29, 2025 /PRNewswire/ -- Alpha Omega CEO and Founder Gautam Ijoor has been named one of the finalists for Ernst & Young's (EY US) prestigious Entrepreneur Of The Year 2025 Mid-Atlantic Award. Alpha Omega is a leading provider of AI-driven modernization, efficiency, and digital transformation solutions within national security, health, space & science, and financial services. Doubling the size of its business through the acquisition of SeKON and Macro Solutions in February, 2025, Alpha Omega has grown to over $139 million in annual revenue in eight years. Alpha Omega is also an award-winning organization named as a top workplace by The Washington Post, USA Today and Virginia Business, and a six-time member of the Inc. 5000. An independent panel of judges selected Mr. Ijoor along with 36 finalists for their entrepreneurial spirit, purpose, growth and lasting impact in building long-term value. 'In the IT and security industries, we pursue processes of continuous improvement, and I consider that a mantra for my life's work. I am so proud to be a part of the entrepreneurial community and to continue to both learn and mentor fellow businesspeople to the benefit of all,' said Mr. Ijoor. 'We know that supporting business and investing in technologies that serve our government and build the next generation of innovators and thinkers is essential to the nation's continued leadership and security. Alpha Omega's mission is to impact how we serve the U.S. and its citizens, collaborating with agencies that affect people's daily lives, from ensuring American food security and legal immigration, to combatting public health challenges.' Now in its 40th year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world's most ground-breaking companies, revolutionizing industries and making a profound impact on communities. The program honors bold entrepreneurs whose innovations shape the future and pave the way for a thriving economy and a hopeful tomorrow. The Mid-Atlantic program celebrates entrepreneurs from Maryland, Virginia, and Washington, DC. Regional award winners will be announced on June 18 during a special celebration in Washington, DC, and will become lifetime members of an esteemed community of Entrepreneur Of The Year alumni from around the world. The winners will then be considered by the National judges for the Entrepreneur Of The Year National Awards, which will be presented in November at the annual Strategic Growth Forum ®, one of the nation's most prestigious gatherings of high-growth, market-leading entrepreneurs. ABOUT ALPHA OMEGA: Alpha Omega delivers mission-focused solutions to ensure our nation's continued global leadership. We accelerate transformation and operational efficiency via applied expertise in digital modernization, artificial intelligence, and cybersecurity, designing and delivering enterprise solutions in support of National Security, Federal Financial, Space and Science, and Healthcare missions. Our agency partners rely on Alpha Omega to modernize and future-proof legacy systems and enhance operational resilience, delivering on our purpose to ensure the safety, security, and well-being of future generations. For more information, visit About Entrepreneur Of The Year Founded in 1986, Entrepreneur Of The Year has celebrated more than 11,000 ambitious visionaries who are leading successful, dynamic businesses in the US, and it has since expanded to nearly 60 countries globally. Entrepreneur Of The Year honors business leaders for their ingenuity, courage and entrepreneurial spirit. The program celebrates original founders who bootstrapped their business from inception or who raised outside capital to grow their company; transformational CEOs who infused innovation into an existing organization to catapult its trajectory; and multigenerational family business leaders who reimagined a legacy business model to strengthen it for the future. The US program consists of 17 regional programs whose panels of independent judges select the regional award winners every June. Those winners compete for national recognition at the Strategic Growth Forum ® in November where National finalists and award winners are announced. The overall National winner represents the US at the EY World Entrepreneur Of The Year™ competition. Visit View original content to download multimedia: SOURCE Alpha Omega

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store